1887
  1. Home
  2. Eurosurveillance
  3. Volume 25, Issue 44, 05/Nov/2020
  4. Article
Research Open Access
Like 1
Download

Abstract

Background

Point-of-care tests (POCT) for influenza A and B viruses and respiratory syncytial virus (RSV) were implemented in emergency departments of all hospitals in the Capital Region of Denmark in 2018.

Aim

To establish whether POC testing for influenza viruses or RSV is based on a valid respiratory symptom indication, whether changes in patient management based on a positive result are safe and whether syndromic POC testing may benefit patients with influenza or RSV.

Methods

Samples from 180 children (< 18 years) and 375 adults tested using POCT between February and July 2018 were retested for 26 respiratory pathogens. Diagnosis, indication for POC testing, hospitalisation time, antimicrobial therapy and readmission or death within one month of testing were obtained from patient records.

Results

A valid indication for POC testing was established in 168 (93.3%) of children and 334 (89.1%) of adults. A positive POCT result significantly reduced antibiotic prescription and median hospitalisation time by 44.3 hours for adults and 14.2 hours for children, and significantly increased antiviral treatment in adults. Risk of readmission or death was not significantly altered by a positive result. Testing for 26 respiratory pathogens established that risk of coinfection is lower with increasing age and that POCT for adults should be restricted to the influenza and RSV season.

Conclusion

Positive POCT resulted in changed patient management for both children and adults, and was deemed safe. POCT for additional pathogens may be beneficial in children below 5 years of age and outside the influenza and RSV season.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2020.25.44.1900430
2020-11-05
2024-04-24
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2020.25.44.1900430
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/25/44/eurosurv-25-44-3.html?itemId=/content/10.2807/1560-7917.ES.2020.25.44.1900430&mimeType=html&fmt=ahah

References

  1. Banerjee D, Kanwar N, Hassan F, Essmyer C, Selvarangan R. Comparison of six sample-to-answer influenza A/B and respiratory syncytial virus nucleic acid amplification assays using respiratory specimens from children. J Clin Microbiol. 2018;56(11):e00930-18.  https://doi.org/10.1128/JCM.00930-18  PMID: 30185508 
  2. Egilmezer E, Walker GJ, Bakthavathsalam P, Peterson JR, Gooding JJ, Rawlinson W, et al. Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection. Rev Med Virol. 2018;28(5):e1995.  https://doi.org/10.1002/rmv.1995  PMID: 30101552 
  3. Hansen GT, Moore J, Herding E, Gooch T, Hirigoyen D, Hanson K, et al. Clinical decision making in the emergency department setting using rapid PCR: Results of the CLADE study group. J Clin Virol. 2018;102:42-9.  https://doi.org/10.1016/j.jcv.2018.02.013  PMID: 29494950 
  4. Brendish NJ, Malachira AK, Armstrong L, Houghton R, Aitken S, Nyimbili E, et al. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med. 2017;5(5):401-11.  https://doi.org/10.1016/S2213-2600(17)30120-0  PMID: 28392237 
  5. Duan S, Gu X, Fan G, Sun R, Wang Y, Yu D, et al. Evaluation of a molecular point of care testing for viral and atypical pathogens on intravenous antibiotic duration in hospitalized adults with lower respiratory tract infection: A randomized clinical trial. Clin Microbiol Infect.  https://doi.org/10.1016/j.cmi.2019.06.012 
  6. Pedersen CJ, Rogan DT, Yang S, Quinn JV. Using a novel rapid viral test to improve triage of emergency department patients with acute respiratory illness during flu season. J Clin Virol. 2018;108:72-6.  https://doi.org/10.1016/j.jcv.2018.09.008  PMID: 30261422 
  7. Andrews D, Chetty Y, Cooper BS, Virk M, Glass SK, Letters A, et al. Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use. BMC Infect Dis. 2017;17(1):671.  https://doi.org/10.1186/s12879-017-2784-z  PMID: 29017451 
  8. Vos LM, Weehuizen JM, Hoepelman AIM, Kaasjager KHAH, Riezebos-Brilman A, Oosterheert JJ. More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients. J Clin Virol. 2019;116:11-7.  https://doi.org/10.1016/j.jcv.2019.04.003  PMID: 30999234 
  9. Busson L, Bartiaux M, Brahim S, Konopnicki D, Dauby N, Gérard M, et al. Contribution of the FilmArray Respiratory Panel in the management of adult and pediatric patients attending the emergency room during 2015-2016 influenza epidemics: An interventional study. Int J Infect Dis. 2019;83:32-9.  https://doi.org/10.1016/j.ijid.2019.03.027  PMID: 30926539 
  10. Kaku N, Hashiguchi K, Iwanaga Y, Akamatsu N, Matsuda J, Kosai K, et al. Evaluation of FilmArray respiratory panel multiplex polymerase chain reaction assay for detection of pathogens in adult outpatients with acute respiratory tract infection. J Infect Chemother. 2018;24(9):734-8.  https://doi.org/10.1016/j.jiac.2018.05.006  PMID: 29895452 
  11. Sakata KK, Azadeh N, Brighton A, Temkit M, Klassen CL, Grys TE, et al. Impact of nasopharyngeal FilmArray respiratory panel results on antimicrobial decisions in hospitalized patients. Can Respir J. 2018;2018:9821426.  https://doi.org/10.1155/2018/9821426  PMID: 30008977 
  12. Vecino-Ortiz AI, Goldenberg SD, Douthwaite ST, Cheng CY, Glover RE, Mak C, et al. Impact of a multiplex PCR point-of-care test for influenza A/B and respiratory syncytial virus on an acute pediatric hospital ward. Diagn Microbiol Infect Dis. 2018;91(4):331-5.  https://doi.org/10.1016/j.diagmicrobio.2018.03.013  PMID: 29706478 
  13. Rahamat-Langendoen J, Groenewoud H, Kuijpers J, Melchers WJG, van der Wilt GJ. Impact of molecular point-of-care testing on clinical management and in-hospital costs of patients suspected of influenza or RSV infection: a modeling study. J Med Virol. 2019;91(8):1408-14.  https://doi.org/10.1002/jmv.25479  PMID: 30950066 
  14. Lisby G, Andersen DT, Chen M, Dreyer A, Greve T, Hansen D, et al. Anbefalinger vedrørende implementering og anvendelse af Point-of-Care teknologi til diagnostik af infektionssygdomme. [Recommendations regarding the implementation and use of point-of-care technology for diagnosis of infectious diseases]. Odense: Dansk Selskab for Klinisk Mikrobiologi (DSKM); 2017. (Danish). Available from: https://dskm.dk/wp-content/uploads/2016/08/POC-Rapport-fra-DSKMs-Udvalg.pdf
  15. Arbefeville S, Ferrieri P. Epidemiologic analysis of respiratory viral infections mainly in hospitalized children and adults in a Midwest university medical center after the implementation of a 14-virus multiplex nucleic acid amplification test. Am J Clin Pathol. 2017;147(1):43-9. PMID: 28028115 
  16. Tsagarakis NJ, Sideri A, Makridis P, Triantafyllou A, Stamoulakatou A, Papadogeorgaki E. Age-related prevalence of common upper respiratory pathogens, based on the application of the FilmArray Respiratory panel in a tertiary hospital in Greece. Medicine (Baltimore). 2018;97(22):e10903.  https://doi.org/10.1097/MD.0000000000010903  PMID: 29851817 
Point-of-care tests for influenza A and B viruses and RSV in emergency departments – indications, impact on patient management and possible gains by syndromic respiratory testing, Capital Region, Denmark, 2018
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Uffe+Vest+Schneider&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Schneider Uffe Vest</a>, <a href="/search?value1=Mona+Katrine+Alberthe+Holm&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Holm Mona Katrine Alberthe</a>, <a href="/search?value1=Didi+Bang&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bang Didi</a>, <a href="/search?value1=Randi+F%C3%B8ns+Petersen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Petersen Randi Føns</a>, <a href="/search?value1=Shila+Mortensen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Mortensen Shila</a>, <a href="/search?value1=Ramona+Trebbien&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Trebbien Ramona</a>, <a href="/search?value1=Jan+Gorm+Lisby&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lisby Jan Gorm</a></span>. Point-of-care tests for influenza A and B viruses and RSV in emergency departments – indications, impact on patient management and possible gains by syndromic respiratory testing, Capital Region, Denmark, 2018. <a href="/content/ecdc">Euro Surveill.</a> 2020;25(44):pii=1900430. <a href="https://doi.org/10.2807/1560-7917.ES.2020.25.44.1900430" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2020.25.44.1900430</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 30 Jun 2019;&nbsp;&nbsp; <span class="generated">Accepted</span>: 06 Jul 2020 </span> </p>
/content/10.2807/1560-7917.ES.2020.25.44.1900430
/content/10.2807/1560-7917.ES.2020.25.44.1900430
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error